Asuragen, Inc.
134 articles about Asuragen, Inc.
-
Asuragen, Inc. Announces New Notice of Allowance from USPTO Related to the Use of a miRNA as a Normalizer for miRNA Gene Expression Analysis
6/2/2011
-
Asuragen, Inc. Announces Launch of Inform(TM) Thyroid Panel in Its CAP Accredited CLIA Laboratory
4/6/2011
-
Asuragen, Inc. Announces Launch of its miRNA Biofluids Service for miRNA Analysis from Serum, Plasma, and More
3/31/2011
-
Asuragen, Inc. Launches CE Marked IVD AmplideX(TM) Fragile X Test in Europe
3/23/2011
-
Asuragen, Inc. Reports Results from a Multi-Center Study on Fragile X Gene Expansion Risk at the Annual Meeting of the American College of Medical Genetics
3/16/2011
-
Asuragen, Inc. Announces New Notices of Allowance from USPTO Related to the Diagnostic Applications of Cancer-Related miRNAs at the JP Morgan Healthcare Conference
1/13/2011
-
Asuragen, Inc. Announces Collaboration on the Development of BCR-ABL1 RNA IS Calibrators and Laboratory Software Reporting Tool at American Society of Hematology
12/6/2010
-
Asuragen, Inc. to Present at Upcoming Association for Molecular Pathology 16th Annual Meeting
11/16/2010
-
Asuragen, Inc. Reports Notice of Allowance from USPTO Related to the Diagnostic Application of an Important Cancer-Related miRNA
11/10/2010
-
Asuragen, Inc. Release: Asuragen, Inc. Researchers Publish Results of Study Evaluating Multiplex Assay for Detection of Common NPM1 Mutations
9/23/2010
-
Asuragen, Inc.'s Clinical Laboratory Launches KRAS and BRAF Mutation Testing
9/1/2010
-
Asuragen, Inc. and Collaborators Report Results Using PCR-Only Technologies for the Comprehensive Molecular Assessment of the Fragile X Gene
7/26/2010
-
Asuragen, Inc. and Life Technologies Launch CE-Marked BCR/ABL1 Quant(TM) Leukemia Test in Europe
7/13/2010
-
Asuragen, Inc. Licenses BRAF Mutation for Molecular Diagnostic Testing
6/2/2010
-
Asuragen, Inc. Appoints Lyle Arnold, Ph.D., to Board of Directors
3/30/2010
-
Asuragen, Inc. Appoints French Distributor Biomedical Diagnostics for Signature(R) Oncology Portfolio
3/22/2010
-
Affymetrix (Santa Clara, California) and Asuragen, Inc. Sign Agreement to Supply RNA Control Kits for Molecular Diagnostic Applications
2/18/2010
-
Asuragen, Inc. (JOBS) Establishes Multi-Center Collaborations with Key Researchers for Development of Diagnostic Test for Pancreatic Cancer
2/1/2010
-
Asuragen, Inc.'s CLIA Laboratory Receives Accreditation from College of American Pathologists
12/17/2009
-
Asuragen, Inc. to Present at Association for Molecular Pathology 15th Annual Meeting
11/19/2009